fMRI Measurements on Pain Relief Methods in First Stage Labor Pain
NCT ID: NCT00768014
Last Updated: 2008-10-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2008-03-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Transcutaneous electrical nerve stimulation (TENS) is one of the non-pharmacological means of pain relief for labor and delivery. We aimed to investigate the efficacy and safety of TENS on specific acupuncture points for reducing pain in the first stage of labor. In this double-blind, placebo-controlled trial, we randomly assigned healthy full-term parturients in active phase of first-stage labor to either TENS on 4 acupuncture points (Hegu \[Li 4\] and Sanyinjiao \[Sp 6\].
Visual analogue scale (VAS) will be used as an adjunct objective assessment of pain relief efficacy by having a scale with a range from 1 to 10, where 1 represented no pain and 10 the most painful. Participants will be asked by study personnel to estimate how painful during the last contractions before the application of TENS, 30 minutes and 60 minutes after TENS application. VAS will be recorded at each application (first, second application, and so forth) as described till the end of first stage. Within 24 hours after delivery, the women will be asked to fill in a questionnaire regarding the satisfaction of pain relief using TENS during labor. Augmentation of labor will be administered to achieve three uterine contractions in 10 minutes in the first stage according to the protocol of induction of labor. Continuous external electronic fetal heart rate monitoring and tocodynamometry are used for fetal surveillance. Polygraph recording of maternal heart rate, transcutaneous oxygen tension, respiratory rate will be used for evaluate the changes. Details of the effect of analgesia in participants switching to it, the progression of cervical dilation and the length of first stage after the application of TENS are recorded. The request for epidural anesthesia or other form of analgesia will be available upon request. Adverse events such as discomfort of movement restriction, skin allergy, or electrical accident were recorded if any. Decision of performing operative delivery was made only according to maternal and fetal indications. fMRI A scan will be collected in between 30-60 minutes after the application TENS. Subjects will be asked to lie supine on the scanner bed and motion artifact will be excluded. MR imaging parameters: Functional scans using 3.0-Tesla Siemens Allegra MRI System equipped for echo-planar imaging. Blood oxygenation level-dependent (BOLD) functional imaging will be carried out using a gradient echo T2-weighted pulse sequence. At least 38 sagittal slices, 3 mm thick with 0.6-mm gap will be performed in each scan. Image collection was preceded by four dummy scans to allow for equilibration of the MRI signal. A3D MPRAGE T1-weighted high-resolution structure dataset was collected before functional imaging to facilitate Talairach transformation and visualization.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Healthy term pregnant women in labor without any pain relief
No interventions assigned to this group
2
Healthy term pregnant women received TENS
No interventions assigned to this group
3
Healthy term pregnant women received epidural anesthesia
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* primigravida
* planned vaginal childbirth without obstetrical or non-obstetrical complications
* fetal vertex presentation
* term pregnancy (\>37 weeks of gestation)
* age between 20 and 40 years
* no experience in acupuncture or TENS for other reasons
* no previous poor obstetrical outcome (either maternal or fetal). For those subjects willing to have fMRI: This study will be carried out only on right-handed Chinese women under accompany by a family member.
Exclusion Criteria
* candidate for vaginal birth after cesarean (VBAC); and
* head trauma with loss of conscious,
* major medical illness e.g., pacemaker parturient.
20 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chang Gung Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chang Gung Memorial Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
An-Shine Chao, MD
Role: PRINCIPAL_INVESTIGATOR
Chang Gung Memorial Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AS Chao
Guishan, Tao-Yuan, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
An-Shine Chao, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
YY Wai
Identifier Type: -
Identifier Source: secondary_id
JJ Wang
Identifier Type: -
Identifier Source: secondary_id
ZH Wang
Identifier Type: -
Identifier Source: secondary_id
97-1707B
Identifier Type: -
Identifier Source: org_study_id